Related Experiment Videos

Using receptor antagonists in binding studies to characterize a mammalian endothelin receptor

J Ruth Wu-Wong¹

¹Abbott Laboratories, Santa Clara, CA, USA.

Methods in Molecular Biology (Clifton, N.J.)

|August 3, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A Novel Vitamin D Receptor Agonist, VS-105, Improves Bone Mineral Density without Affecting Serum Calcium in a Postmenopausal Osteoporosis Rat Model.

Journal of exploratory research in pharmacology·2021

Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.

The Journal of steroid biochemistry and molecular biology·2016

Preclinical studies of VS-505: a non-absorbable highly effective phosphate binder.

British journal of pharmacology·2016

Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.

American journal of physiology. Renal physiology·2014

Different vitamin D receptor agonists exhibit differential effects on endothelial function and aortic gene expression in 5/6 nephrectomized rats.

The Journal of steroid biochemistry and molecular biology·2014

VS-501: A NOVEL, NON-ABSORBED, CALCIUM- AND ALUMINUM-FREE, HIGHLY EFFECTIVE PHOSPHATE BINDER DERIVED FROM NATURAL PLANT POLYMER.

Pharmacology research & perspectives·2014

See all related articles